Art

J-GLOBAL ID：202002277468293042   Reference number：20A0027241

Risk stratification and clinical course of hepatitis B virus reactivation in rheumatoid arthritis patients with resolved infection: final report of a multicenter prospective observational study at Japanese Red Cross Hospital

感染症を有する関節リウマチ患者におけるB型肝炎ウイルス再活性化のリスク層別化と臨床経過:日本赤十字病院における多施設前向き観察研究の最終報告【JST・京大機械翻訳】

Author (20)： Fukuda Wataru (Center for Rheumatic Disease, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto City, Japan) ,  Hanyu Tadamasa (Department of Rheumatology, Nagaoka Red Cross Hospital, Nagaoka-shi, Japan) ,  Katayama Masaki (Department of Rheumatology, Osaka Red Cross Hospital, Osaka city, Japan) ,  Mizuki Shinichi (The Center for Rheumatic Diseases, Matsuyama Red Cross Hospital, Matsuyama city, Japan) ,  Okada Akitomo (Department of Rheumatology, Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki city, Japan) ,  Miyata Masayuki (Department of Internal Medicine, Japanese Red Cross Fukushima Hospital, Fukushima city, Japan) ,  Handa Yuichi (Department of Rheumatology, Saitama Red Cross Hospital, Saitama city, Japan) ,  Hayashi Masatoshi (Department of Orthopedic Surgery and Rheumatology, Nagano Red Cross Hospital, Nagano city, Japan) ,  Koyama Yoshinobu (Department of Rheumatology, Japanese Red Cross Okayama Hospital, Okayama city, Japan) ,  Arii Kaoru (Department of Internal Medicine, Japanese Red Cross Kochi Hospital, Kochi city, Japan) ,  Kitaori Toshiyuki (Department of Orthopedic Surgery, Japanese Red Cross Fukui Hospital, Fukui city, Japan) ,  Hagiyama Hiroyuki (Department of Rheumatology, Yokohama City Minato Red Cross Hospital, Yokohama city, Japan) ,  Urushidani Yoshinori (Department of Rheumatology, Matsue Red Cross Hospital, Matsue city, Japan) ,  Yamasaki Takahito (Department of Orthopedic Surgery, Tanabe Chuo Hospital, Kyotanabe city, Japan) ,  Ikeno Yoshihiko (Department of Rheumatology, Nasu Red Cross Hospital, Otawara city, Japan) ,  Suzuki Takeshi (Division of Allergy and Rheumatology, Japanese Red Cross Medical Center, Shibuya-ku, Japan) ,  Omoto Atsushi (Center for Rheumatic Disease, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto City, Japan) ,  Sugitani Toshifumi (Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, Kyoto City, Japan) ,  Morita Satoshi (Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, Kyoto City, Japan) ,  Inokuma Shigeko (Department of Allergy and Rheumatology, Chiba Central Medical Center, Chiba city, Japan)
Material： Arthritis Research & Therapy (Web)
Volume： 21  Issue： 1  Page： 1-9  Publication year： 2019 
JST Material Number： U7412A  ISSN： 1478-6362  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Abstract/Point： The prophylaxis for hepatitis ...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A0027241&from=J-GLOBAL&jstjournalNo=U7412A") }}

Thesaurus term： *Hepatitis B virus ,  *rheumatoid arthritis ,  Real Time Polymerase Chain Reaction ,  Prognosis ,  *metabasis ,  risk factor ,  Organ Transplantation ,  optimization ,  antibody ,  hepatic dysfunction ,  *hepatitis B ,  immunosuppressant ,  *infectious disease ,  fulminant hepatitis ,  risk assessment ,  *microorganism ,  *Hepatitis Viruses ,  *Hepadnaviridae ,  modification

Author keywords (5)： Hepatitis B virus ,  Rheumatoid arthritis ,  Reactivation ,  Nucleic acid analog ,  Prognosis

JST classification (2)： Musculoskeletal diseases  (GG03000T) ,  Immunologic diseases,allergic diseases in general.  (GD04010C)

Reference (21)：

• Gastroenterology.; Hepatitis B reactivation associated with immune suppressive and biological modifier therapies: current concepts, management strategies and future directions; R Loomba, TJ Liang; 152; 2017; 1297-1309; 10.1053/j.gastro.2017.02.009; citation_id=CR1
• Ann Rheum Dis; Incidence of hepatitis B virus reactivation in patients with resolved infection on immunosuppressive therapy for rheumatic disease: a multicentre prospective observational study in Japan; W Fukuda, T Hanyu, M Katayama, S Mizuki, A Okada, M Miyata; 76; 2017; 1051-1056; 10.1136/annrheumdis-2016-209973; citation_id=CR2
• Hepatol Res; Etiology and prognosis of fulminant hepatitis and late onset hepatic failure in Japan: summary of the annual nationwide survey between 2004 and 2009; M Oketani, A Ido, N Nakayama, Y Takikawa, T Naiki, Y Yamagishi; 43; 2013; 97-105; 10.1111/j.1872-034X.2012.01105.x; citation_id=CR3
• Clinical Infectious Diseases; Mortality Secondary to Fulminant Hepatic Failure in Patients with Prior Resolution of Hepatitis B Virus Infection in Japan; Takeji Umemura, Eiji Tanaka, Kendo Kiyosawa, Hiromitsu Kumada; 47; 5; 2008; e52-e56; 10.1086/590968; citation_id=CR4
• Acta Hepatol Jpn; Prevention of immunosuppressive therapy or chemotherapy-induced reactivation of hepatitis B virus infection-joint report of the Intractable Liver Disease Study Group of Japan and the Japanese Study Group of the Standard Antiviral Therapy for Viral Hepatitis; H Tsubouchi, H Kumada, K Kiyosawa, S Mochida, I Sakaid, E Tanaka; 50; 2009; 38-42; 10.2957/kanzo.50.38; citation_id=CR5

Terms in the title (14)： 感染症 ,  関節リウマチ ,  患者 ,  B型肝炎ウイルス ,  再活性化 ,  リスク層別化 ,  臨床経過 ,  日本 ,  赤十字 ,  病院 ,  施設 ,  観察 ,  研究 ,  報告